中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
23期
106-107
,共2页
布地奈德%沙丁胺醇%雾化吸入%支气管哮喘
佈地奈德%沙丁胺醇%霧化吸入%支氣管哮喘
포지내덕%사정알순%무화흡입%지기관효천
Budesonide%Albuterol%Aerosol inhalation%Bronchial asthma
目的:探讨布地奈德联合沙丁胺醇雾化吸入治疗支气管哮喘的临床疗效。方法随机选取2013年5月—2014年4月在该院就诊的支气管哮喘患者100例,按照随机数字表法将100例支气管哮喘患者随机分为观察组(50例)和对照组(50例),对照组患者采用布地奈德雾化吸入治疗,观察组患者采用布地奈德联合沙丁胺醇雾化吸入治疗,观察并记录组两组患者咳嗽、哮鸣音、喘息消失时间及住院时间。结果观察组患者哮鸣音消失时间、喘息消失时间、咳嗽消失时间及住院时间均显著少于对照组,P<0.05;观察组总有效率(92.00%)显著高于对照组总有效率(74.00%),P<0.05;两组不良反应发生率差异无统计学意义,P>0.05。结论布地奈德与沙丁胺醇联合雾化吸人治疗支气管哮喘,安全有效,值得临床推广。
目的:探討佈地奈德聯閤沙丁胺醇霧化吸入治療支氣管哮喘的臨床療效。方法隨機選取2013年5月—2014年4月在該院就診的支氣管哮喘患者100例,按照隨機數字錶法將100例支氣管哮喘患者隨機分為觀察組(50例)和對照組(50例),對照組患者採用佈地奈德霧化吸入治療,觀察組患者採用佈地奈德聯閤沙丁胺醇霧化吸入治療,觀察併記錄組兩組患者咳嗽、哮鳴音、喘息消失時間及住院時間。結果觀察組患者哮鳴音消失時間、喘息消失時間、咳嗽消失時間及住院時間均顯著少于對照組,P<0.05;觀察組總有效率(92.00%)顯著高于對照組總有效率(74.00%),P<0.05;兩組不良反應髮生率差異無統計學意義,P>0.05。結論佈地奈德與沙丁胺醇聯閤霧化吸人治療支氣管哮喘,安全有效,值得臨床推廣。
목적:탐토포지내덕연합사정알순무화흡입치료지기관효천적림상료효。방법수궤선취2013년5월—2014년4월재해원취진적지기관효천환자100례,안조수궤수자표법장100례지기관효천환자수궤분위관찰조(50례)화대조조(50례),대조조환자채용포지내덕무화흡입치료,관찰조환자채용포지내덕연합사정알순무화흡입치료,관찰병기록조량조환자해수、효명음、천식소실시간급주원시간。결과관찰조환자효명음소실시간、천식소실시간、해수소실시간급주원시간균현저소우대조조,P<0.05;관찰조총유효솔(92.00%)현저고우대조조총유효솔(74.00%),P<0.05;량조불량반응발생솔차이무통계학의의,P>0.05。결론포지내덕여사정알순연합무화흡인치료지기관효천,안전유효,치득림상추엄。
Objective Observe the clinical efficacy of budesonide combined ventolin atomizing inhalation in the treatment of bronchial asthma. Methods According to random number table method, 100 cases of patients from 2013 May to 2014 April with bronchial asthma were randomly divided into observation group (50 cases) and control group (50 cases), and control group were treated by budesonide aerosol inhalation treatment, the observation group were treated by budesonide combined ventolin atomizing inhalation therapy. Results Observation group of patients with wheezing sound disappear time, breathing, cough disappeared time and length of hospital stay, were significantly less than the control group, P<0.05; Observation group total effective rate (92.00%) is significantly higher than the control group total effective (74.00%),P<0.05;The incidence of adverse reactions similar between the two groups have no statistical significance,P > 0.05 Conclusion Joint atomization inhalation of budesonide and salbutamol treatment of bronchial asthma, is safe and effective, and worthy of clinical promotion.